Renal disease, a progressive loss of proper functioning of the kidneys and associated renal system over a longer period of time is fueling the market because of its high incidence rate worldwide.
The market for global renal medical devices & services are segmented on the basis of 1) Type (Dialysis equipment which further includes Peritoneal Dialysis equipment, hemodialysis equipment, hemofiltration equipment, hemodiafiltration equipment, intestinal dialysis equipment and CRRT), Renal Denervation devices, Wearable artificial kidney and distal embolic protection devices 2) Application ( kidney failure, chronic kidney disease, end-stage kidney disease, Renal kidney stone disease, hypertension, diabetes, and anemia) and 3) Geographical Terrains.
Patients with kidney disease can now look forward for innovative technologies and treatment concepts like modern dialysis methods for best possible quality of life. Medical support by reimbursement and funding for renal diseases especially ESRD has a substantial share of health expenditure. Governments around the world are using various reimbursement strategies depending upon the type of dialysis and medical condition, there by balancing cost and quality care.
Geographically, North America holds the leading position for this market and Europe is found almost closer to it. Asia Pacific region is expected to show high growth in the near future due to increasing number of diabetic and high blood pressure patients that ultimately lead to kidney disease, rising healthcare awareness and increasing demand for advanced diagnostics and therapeutics for renal diseases.
Some of the major players operating in the renal medical devices & services market are Fresenius Medical (Germany), DaVita Healthcare Partners, Inc. (U.S.), Gambro AB (Sweden), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Nipro Corporation (Japan), Medical Components, Inc. (U.S.), Covidien (Ireland), NxStage Medical, Inc. (U.S.), Infomed SA (Switzerland), Nikkiso Co., Ltd (Japan), Medtronic(US), St. Jude Medical, Inc.(US),Boston Scientific Corporation and others.
The growth of the market for global renal medical devices & services is fueled by factors like increasing incidences of kidney diseases worldwide, increasing number of individuals suffering from diabetes, high blood pressure etc., aging population, rising demand for advanced therapeutics for the disease and increasing awareness and affordability of the people.
The factors constraining growth of this market majorly include reimbursement issues and low awareness about kidney disease in some regions.
Key Deliverables in the Study?
1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.
2) Market analysis for Global Stem Cell Banking Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.
3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.
4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.
5)Identification and analysis of the Macro and Micro factors that affect the Global Stem Cell Banking Market in Healthcare Industry on both global and regional scale.
6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
1.1 Report Description
1.2 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Increasing incidences of kidney diseases
3.2.2 Increase in diabetes, high blood pressure conditions
3.2.3 Aging population
3.2.4 Rising demand for advanced therapies
3.2.5 Increasing awareness and affordability
3.3 Market restraints
3.3.1 Reimbursement issues
3.3.2 Lack of awareness in few regions
4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
5.1 By Type
5.1.1 Dialysis Equipment
18.104.22.168 Peritoneal Dialysis equipment
22.214.171.124 Hemodialysis equipment
126.96.36.199.1 Blood tubing set
188.8.131.52.2 Endotoxin Retention Filter
184.108.40.206.3 AV-Access Device and accessories
220.127.116.11 Hemofiltration equipment
18.104.22.168 Hemodiafiltration equipment
22.214.171.124 Intestinal dialysis equipment
126.96.36.199.1 CRRT disposables
188.8.131.52.2 CRRT dialysate and replacement fluids
184.108.40.206.3 CRRT system
5.1.2 Renal Denervation devices
220.127.116.11 Ultrasound-based renal denervation systems
18.104.22.168 Renal sympathetic denervation devices
22.214.171.124 Radiofrequency-based renal denervation systems
126.96.36.199 Micro-infusion catheter-based renal denervation systems
5.1.3 Wearable artificial kidney device
5.1.4 distal embolic protection devices
188.8.131.52 Filter baskets
184.108.40.206 Distal occlusion balloons
220.127.116.11 Proximal occlusion balloons
5.2 By Application
5.2.1 kidney failure
5.2.2 chronic kidney disease
5.2.3 end-stage kidney disease
5.2.4 Renal kidney stone disease
5.3 By Geography
5.3.1 North America
18.104.22.168 Scandinavian Regions
22.214.171.124 Rest of Europe
5.3.4 Rest of the World
6. Competitive Landscape
7. Company Profiles
7.1 Fresenius Medical
7.2 DaVita Healthcare Partners, Inc.
7.3 Baxter International, Inc.
7.4 B. Braun Melsungen AG
7.5 Nipro Corporation
7.7 Infomed SA
7.9 St. Jude Medical, Inc
7.10 Boston Scientific Corporation